S2Medical AB Class B (S21) Stock Statistics & Valuation Metrics
Total Valuation
S2Medical AB Class B has a market cap or net worth of EUR 628.72K. The enterprise value is EUR 4.15M.
- Market Cap
- EUR 628.72K
- Enterprise Value
- EUR 4.15M
Share Statistics
S2Medical AB Class B has 1,797,314,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,797,314,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
S2Medical AB Class B’s return on equity (ROE) is -1.02 and return on invested capital (ROIC) is -27.16%.
- Return on Equity (ROE)
- -1.02
- Return on Assets (ROA)
- -0.60
- Return on Invested Capital (ROIC)
- -27.16%
- Return on Capital Employed (ROCE)
- -0.27
- Revenue Per Employee
- 1.44M
- Profits Per Employee
- -1.01M
- Employee Count
- 10
- Asset Turnover
- 0.85
- Inventory Turnover
- 41.75
Valuation Ratios
The current PE Ratio of S2Medical AB Class B is -0.32. S2Medical AB Class B’s PEG ratio is 0.00.
- PE Ratio
- -0.32
- PS Ratio
- 0.28
- PB Ratio
- 0.34
- Price to FCF
- -10.35
- Price to Operating Cash Flow
- -7.79
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, S2Medical AB Class B had revenue of 14.36M and earned -10.09M in profits. Earnings per share was -0.01.
- Revenue
- 14.36M
- Gross Profit
- -2.07M
- Operating Income
- -2.68M
- Pretax Income
- -10.09M
- Net Income
- -10.09M
- EBITDA
- -1.41M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -444.79K and capital expenditures 0, giving a free cash flow of -444.79K billion.
- Operating Cash Flow
- -444.79K
- Free Cash Flow
- -444.79K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
S2Medical AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.66%
- Earnings Yield
- -290.66%
Stock Price Statistics
- Beta
- 13.32
- 52-Week Price Change
- -42.86%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
S2Medical AB Class B upcoming earnings date is Nov 30, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 21, 2026
- Next Earnings Date
- Nov 30, 2026
- Ex-Dividend Date
- ―
Financial Position
S2Medical AB Class B as a current ratio of 0.56, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.56
- Quick Ratio
- 0.51
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.65
- Interest Coverage Ratio
- -446.83
Taxes
In the past 12 months, S2Medical AB Class B has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
S2Medical AB Class B EV to EBITDA ratio is -5.43, with an EV/FCF ratio of -9.08.
- EV to Sales
- 0.25
- EV to EBITDA
- -5.43
- EV to Free Cash Flow
- -9.08
- EV to Operating Cash Flow
- -9.08
Balance Sheet
S2Medical AB Class B has EUR 564.00K in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 564.00K billion.
- Cash & Marketable Securities
- EUR 564.00K
- Total Debt
- EUR 0.00
- Net Cash
- EUR 564.00K
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.01
Margins
Gross margin is 89.39%, with operating margin of -11.92%, and net profit margin of -62.11%.
- Gross Margin
- 89.39%
- Operating Margin
- -11.92%
- Pretax Margin
- -57.50%
- Net Profit Margin
- -62.11%
- EBITDA Margin
- -4.59%
- EBIT Margin
- -11.92%
